SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-039305
Filing Date
2024-04-01
Accepted
2024-04-01 16:05:12
Documents
11
Period of Report
2024-03-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K dvax-20240329.htm   iXBRL 8-K 37285
  Complete submission text file 0000950170-24-039305.txt   146635

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dvax-20240329.xsd EX-101.SCH 23882
14 EXTRACTED XBRL INSTANCE DOCUMENT dvax-20240329_htm.xml XML 4534
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 24809085
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)